Invention Grant
- Patent Title: Triazolopyrimidine compounds and uses thereof
-
Application No.: US17505271Application Date: 2021-10-19
-
Publication No.: US11931363B2Publication Date: 2024-03-19
- Inventor: Ho Man Chan , Xiang-Ju Justin Gu , Ying Huang , Ling Li , Yuan Mi , Wei Qi , Martin Sendzik , Yongfeng Sun , Long Wang , Zhengtian Yu , Hailong Zhang , Ji Yue (Jeff) Zhang , Man Zhang , Qiong Zhang , Kehao Zhao
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent Daniel E. Raymond
- Priority: WO TCN2014094644 2014.12.23 WO TCN2015095320 2015.11.23
- Main IPC: C07D307/78
- IPC: C07D307/78 ; A61K31/519 ; A61K31/5377 ; A61K31/541 ; A61K31/551 ; A61K45/06 ; C07D307/79 ; C07D307/83 ; C07D487/04
Abstract:
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder:
wherein R1, R2, R3, R4, R5, and n are as defined herein.
wherein R1, R2, R3, R4, R5, and n are as defined herein.
Public/Granted literature
- US20230033320A1 TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF Public/Granted day:2023-02-02
Information query
